Overview

A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

Status:
Recruiting

Trial end date:
2026-06-15

Target enrollment:

Participant gender:

Summary

This study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednisone per local regulation.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Abiraterone Acetate
Prednisone